Articles
Showing 1–12 of 169 resultsSorted by latest
-
The impact of innovative medicines on healthcare costs in Canada 1990 to 2024: $20 billion cumulative annual variation in spending on patent drugs saved $70 billion in overall public healthcare expenditure.
Read more -
Reimbursement recommendations for new medicines in Canada: current trends in an uncertain era
Read more -
Canada’s medication spending has been relatively low; may need to be reconsidered because of US “most-favored nation” pharma pricing policy
Read more -
Does Canada pay its fair share of the global cost of pharmaceutical innovation?
Read more -
The Economic Burden of Seasonal Influenza in Quebec: Updated Estimates and Policy Implications
Read more -
Bulk purchasing for innovative pharmaceuticals – proceed with caution
Read more -
Net direct expenditure on patented medicines by public drug plans in 10 Canadian provinces in 2023
Read more -
Documenting Long-Acting Reversible Contraceptive (LARC) Coverage Across Canada
Read more -
Judicial perspectives on the use of class action litigation as a tool for health policy change
Read more -
Access to new drugs on public formularies in 10 Canadian provinces 2019 to 2024
Read more -
The impact of pharmaceutical innovation on mortality and hospital utilization in Canada, 2000–2022
Read more -
Lessons from Abroad for Canada’s National Dementia Strategy: Actions for Implementation
Read more